rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
47
|
pubmed:dateCreated |
2003-11-17
|
pubmed:abstractText |
The ETS family transcriptional repressor TEL is frequently disrupted by chromosomal translocations, including the t(12;21) in which the second allele of TEL is deleted in up to 90% of the cases. Consistent with its role as a putative tumor suppressor, TEL expression inhibits colony formation by Ras-transformed NIH 3T3 cells and hinders proliferation of a variety of cell types. Although we observed no alteration in the cell cycle of TEL-expressing cells, we did find a marked increase in apoptosis of serum-starved TEL-expressing NIH 3T3 cells. This decrease in cell survival required the DNA binding domain of TEL, suggesting that TEL repressed an anti-apoptotic gene. These observations prompted us to search for genes regulated by ETS family proteins that regulate apoptosis. The anti-apoptotic molecule Bcl-XL contains multiple ets-factor binding sites within its promoters, and TEL repressed a Bcl-XL promoter-linked reporter gene. Moreover, the enforced expression of TEL decreased the endogenous expression of both Bcl-XL mRNA and protein. TEL-mediated repression of Bcl-XL likely affects cell survival via regulation of the apoptotic pathway.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bcl2l1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, Serum-Free,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/ETS translocation variant 6 protein,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-ets,
http://linkedlifedata.com/resource/pubmed/chemical/Repressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-X Protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-9258
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
278
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
46378-86
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12960174-3T3 Cells,
pubmed-meshheading:12960174-Animals,
pubmed-meshheading:12960174-Apoptosis,
pubmed-meshheading:12960174-Binding Sites,
pubmed-meshheading:12960174-Culture Media, Serum-Free,
pubmed-meshheading:12960174-DNA-Binding Proteins,
pubmed-meshheading:12960174-Gene Expression Regulation,
pubmed-meshheading:12960174-Mice,
pubmed-meshheading:12960174-Promoter Regions, Genetic,
pubmed-meshheading:12960174-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:12960174-Proto-Oncogene Proteins c-ets,
pubmed-meshheading:12960174-Repressor Proteins,
pubmed-meshheading:12960174-Transcription, Genetic,
pubmed-meshheading:12960174-Tumor Suppressor Proteins,
pubmed-meshheading:12960174-bcl-X Protein
|
pubmed:year |
2003
|
pubmed:articleTitle |
TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL.
|
pubmed:affiliation |
Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Preston Research Building, 23rd and Pierce, Nashville, TN 37232, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|